Published in Am J Hum Genet on April 10, 2003
RNA processing and its regulation: global insights into biological networks. Nat Rev Genet (2010) 5.34
Genome-wide identification of genes likely to be involved in human genetic disease. Nucleic Acids Res (2004) 2.86
Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A (2008) 2.41
WHEP domains direct noncanonical function of glutamyl-Prolyl tRNA synthetase in translational control of gene expression. Mol Cell (2008) 2.34
New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol (2010) 2.22
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet (2009) 2.21
Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A (2011) 2.11
ATP7A-related copper transport diseases-emerging concepts and future trends. Nat Rev Neurol (2011) 2.01
Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet (2010) 1.96
Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci U S A (2007) 1.91
Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet (2004) 1.91
A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet (2009) 1.80
Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. Am J Hum Genet (2014) 1.71
Gain-of-function mutational activation of human tRNA synthetase procytokine. Chem Biol (2007) 1.71
Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet (2010) 1.70
Aminoacyl-tRNA synthetases in medicine and disease. EMBO Mol Med (2013) 1.67
Update on Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep (2011) 1.66
CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature (2015) 1.64
Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat Rev Cancer (2011) 1.54
Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am J Hum Genet (2013) 1.46
Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc Natl Acad Sci U S A (2007) 1.46
Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell (2014) 1.40
GARS axonopathy: not every neuron's cup of tRNA. Trends Neurosci (2010) 1.40
Transfer RNA and human disease. Front Genet (2014) 1.35
The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet (2007) 1.33
Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy. Am J Hum Genet (2013) 1.32
Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet (2004) 1.30
Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet (2011) 1.25
Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet (2011) 1.24
An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech (2009) 1.22
Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy. Proc Natl Acad Sci U S A (2009) 1.21
Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am J Hum Genet (2012) 1.16
A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat (2012) 1.15
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Hum Mutat (2011) 1.14
Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening. Proc Natl Acad Sci U S A (2011) 1.14
Mitochondria: impaired mitochondrial translation in human disease. Int J Biochem Cell Biol (2014) 1.13
Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry (2013) 1.09
An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci (2010) 1.08
RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci (2012) 1.07
Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control. Proc Natl Acad Sci U S A (2011) 1.06
The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan. PLoS One (2011) 1.05
Inherited neuropathies: clinical overview and update. Muscle Nerve (2013) 1.05
Inherited peripheral neuropathies. Neurol Clin (2013) 1.04
Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci (2007) 1.04
Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Hum Mol Genet (2009) 1.02
Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32. Neurology (2010) 1.02
Misfolded human tRNA isodecoder binds and neutralizes a 3' UTR-embedded Alu element. Proc Natl Acad Sci U S A (2011) 1.01
Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2. J Inherit Metab Dis (2011) 0.99
RNA processing defects associated with diseases of the motor neuron. Muscle Nerve (2010) 0.99
Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology (2012) 0.99
Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria. J Biol Chem (2008) 0.98
Molecular genetics of charcot-marie-tooth disease: from genes to genomes. Mol Syndromol (2012) 0.97
MSC p43 required for axonal development in motor neurons. Proc Natl Acad Sci U S A (2009) 0.97
A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease. Eur J Hum Genet (2012) 0.96
To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations. Curr Opin Genet Dev (2013) 0.94
Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35. Am J Hum Genet (2003) 0.93
Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Hum Mutat (2014) 0.92
Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum Mol Genet (2013) 0.92
Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Adv Exp Med Biol (2014) 0.92
A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36. Hum Genet (2007) 0.91
Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor. Sci Rep (2015) 0.90
Inherited neuropathies. Semin Neurol (2012) 0.89
Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol (2014) 0.89
Compound heterozygous mutations in glycyl-tRNA synthetase are a proposed cause of systemic mitochondrial disease. BMC Med Genet (2014) 0.89
Crystallization and preliminary X-ray analysis of a native human tRNA synthetase whose allelic variants are associated with Charcot-Marie-Tooth disease. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.88
Mapping and exome sequencing identifies a mutation in the IARS gene as the cause of hereditary perinatal weak calf syndrome. PLoS One (2013) 0.88
CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila. Neurobiol Dis (2014) 0.87
Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases. Nat Commun (2015) 0.87
A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet (2004) 0.87
Comparison of CMT1A and CMT2: similarities and differences. J Neurol (2006) 0.86
A brief review of recent Charcot-Marie-Tooth research and priorities. F1000Res (2015) 0.86
A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D). J Mol Histol (2013) 0.86
The Genetics of Spinal Muscular Atrophy: Progress and Challenges. Neurotherapeutics (2015) 0.86
Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d. J Neurosci (2016) 0.86
Severe Developmental Delay in a Patient with 7p21.1-p14.3 Microdeletion Spanning the TWIST Gene and the HOXA Gene Cluster. Mol Syndromol (2011) 0.85
Classification and diagnosis of the inherited neuropathies. Ann Indian Acad Neurol (2009) 0.85
Expression profile of aminoacyl-tRNA synthetases in dorsal root ganglion neurons after peripheral nerve injury. J Mol Histol (2014) 0.85
Concurrent Lpin1 and Nrcam mouse mutations result in severe peripheral neuropathy with transitory hindlimb paralysis. J Neurosci (2009) 0.85
RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway. J Neurosci (2014) 0.85
A novel AARS mutation in a family with dominant myeloneuropathy. Neurology (2015) 0.84
tRNA synthetase: tRNA aminoacylation and beyond. Wiley Interdiscip Rev RNA (2014) 0.84
Dissociating quaternary structure regulates cell-signaling functions of a secreted human tRNA synthetase. J Biol Chem (2011) 0.84
Cocrystal structures of glycyl-tRNA synthetase in complex with tRNA suggest multiple conformational states in glycylation. J Biol Chem (2014) 0.84
An investigation of genome-wide associations of hypertension with microsatellite markers in the family blood pressure program (FBPP). Hum Genet (2007) 0.84
Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology. Hum Mol Genet (2015) 0.84
Charcot-Marie-Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation. J Neurol (2010) 0.83
Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS. J Peripher Nerv Syst (2012) 0.83
Neddylation requires glycyl-tRNA synthetase to protect activated E2. Nat Struct Mol Biol (2016) 0.82
Mutant glycyl-tRNA synthetase (Gars) ameliorates SOD1(G93A) motor neuron degeneration phenotype but has little affect on Loa dynein heavy chain mutant mice. PLoS One (2009) 0.82
A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition. Hum Genet (2016) 0.82
Charcot-Marie-Tooth disease and intracellular traffic. Prog Neurobiol (2012) 0.81
Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease. PLoS One (2015) 0.81
A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance. Am J Hum Genet (2013) 0.81
Double-sieving-defective aminoacyl-tRNA synthetase causes protein mistranslation and affects cellular physiology and development. Nat Commun (2014) 0.81
Biallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy. Am J Hum Genet (2016) 0.81
Identification of lethal mutations in yeast threonyl-tRNA synthetase revealing critical residues in its human homolog. J Biol Chem (2014) 0.80
Autosomal dominant late-onset spinal motor neuronopathy is linked to a new locus on chromosome 22q11.2-q13.2. Eur J Hum Genet (2012) 0.80
Charcot-marie-tooth disease: seventeen causative genes. J Clin Neurol (2006) 0.80
The aminoacyl-tRNA synthetases of Drosophila melanogaster. Fly (Austin) (2015) 0.79
Architecture and metamorphosis. Top Curr Chem (2014) 0.78
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet (1974) 5.80
Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol (1968) 3.80
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet (2003) 3.22
An empirical energy function for threading protein sequence through the folding motif. Proteins (1993) 2.94
A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet (2000) 2.17
Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet (1997) 1.65
Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet (1996) 1.54
Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum Mol Genet (1995) 1.32
Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15. J Neurol Sci (1998) 1.25
Glycyl-tRNA synthetase. Biol Chem Hoppe Seyler (1996) 1.20
Charcot-Marie-Tooth disease and related inherited neuropathies. Medicine (Baltimore) (1996) 1.20
The carpal tunnel syndrome. J Emerg Med (1999) 1.08
Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. Neurogenetics (1997) 1.03
The CMT2D locus: refined genetic position and construction of a bacterial clone-based physical map. Genome Res (1999) 1.01
Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res (2004) 24.52
Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature (2004) 24.40
LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res (2003) 23.03
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
Distribution and intensity of constraint in mammalian genomic sequence. Genome Res (2005) 18.85
Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96
A vision for the future of genomics research. Nature (2003) 14.06
Prepublication data sharing. Nature (2009) 12.24
Identification and characterization of multi-species conserved sequences. Genome Res (2003) 10.18
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res (2004) 9.18
A high-resolution map of human evolutionary constraint using 29 mammals. Nature (2011) 8.67
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell (2003) 7.71
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome. Genome Res (2007) 7.05
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 7.03
The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res (2009) 6.83
Toxic proteins in neurodegenerative disease. Science (2002) 5.82
Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res (2010) 5.76
Mutant dynactin in motor neuron disease. Nat Genet (2003) 5.28
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
MultiPipMaker and supporting tools: Alignments and analysis of multiple genomic DNA sequences. Nucleic Acids Res (2003) 4.97
A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature (2005) 4.92
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
No gene is an island: the flip-flop phenomenon. Am J Hum Genet (2007) 4.69
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
An intermediate grade of finished genomic sequence suitable for comparative analyses. Genome Res (2004) 4.38
An initial strategy for the systematic identification of functional elements in the human genome by low-redundancy comparative sequencing. Proc Natl Acad Sci U S A (2005) 4.38
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol (2012) 4.12
Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet (2008) 4.04
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci (2004) 3.56
Quantitative estimates of sequence divergence for comparative analyses of mammalian genomes. Genome Res (2003) 3.52
Transcription-associated mutational asymmetry in mammalian evolution. Nat Genet (2003) 3.52
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48
Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc Natl Acad Sci U S A (2004) 3.41
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39
Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet (2008) 3.27
Research ethics. The complexities of genomic identifiability. Science (2013) 3.23
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
The DNA sequence of human chromosome 7. Nature (2003) 3.18
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest (2007) 3.11
TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat Genet (2011) 3.06
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet (2006) 3.04
Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A (2007) 3.03
Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet (2002) 2.90
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet (2003) 2.89
Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet (2004) 2.86
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol (2008) 2.85
Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet (2005) 2.79
Systematic sequencing of cDNA clones using the transposon Tn5. Nucleic Acids Res (2002) 2.78
MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain (2006) 2.77
Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet (2002) 2.70
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61
VarSifter: visualizing and analyzing exome-scale sequence variation data on a desktop computer. Bioinformatics (2011) 2.47
Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat Genet (2002) 2.39
Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett (2004) 2.36
Distal spinal and bulbar muscular atrophy caused by dynactin mutation. Ann Neurol (2005) 2.34
Confirming the phylogeny of mammals by use of large comparative sequence data sets. Mol Biol Evol (2008) 2.33
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet (2009) 2.32
The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet (2008) 2.28
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet (2011) 2.28
Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol (2003) 2.28
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol (2011) 2.27
Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron (2009) 2.26
The completion of the Mammalian Gene Collection (MGC). Genome Res (2009) 2.21
Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biol (2010) 2.20
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Parallel construction of orthologous sequence-ready clone contig maps in multiple species. Genome Res (2002) 2.18
Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics (2002) 2.16
SNPselector: a web tool for selecting SNPs for genetic association studies. Bioinformatics (2005) 2.14
Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology (2011) 2.14
Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol (2003) 2.14
Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genet (2010) 2.14
A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J Cell Biol (2006) 2.08
Analysis of primate genomic variation reveals a repeat-driven expansion of the human genome. Genome Res (2003) 2.07
Regulation of SMN protein stability. Mol Cell Biol (2008) 2.02
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol (2003) 2.01
Reconstructing large regions of an ancestral mammalian genome in silico. Genome Res (2004) 2.01
Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet (2006) 2.00
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet (2003) 1.98
Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol (2006) 1.98
Regulatory divergence modifies limb length between mammals. Genes Dev (2008) 1.96